The PennZone

  • Home
  • Non-profit
  • Technology
  • Education
  • Business
  • Construction
  • Entertainment
  • Health
  • Legal

Lockton Announces Leadership for Life Sciences Practice
The PennZone/10223875

Trending...
  • CAPHRA warns Southeast Asia not to repeat Australia's nicotine policy failure
  • USA Med Bed Helping Home Care Patients with Refurbished Hill Rom Hospital Beds
  • KRE PRIME Launches Adaptive Convertible Jumpsuit
PHILADELPHIA, March 13, 2023 ~ Lockton, the world's largest privately held insurance brokerage, has appointed Brad Zechman and David Salvucci as co-leaders of its Life Sciences Practice. Both Zechman and Salvucci are based in Philadelphia and bring decades of experience in the Life Sciences industry to their new roles.

Zechman and Salvucci join Lockton from Aon, where they managed client relationships, led brokerage teams, and designed innovative property and casualty programs for global, mid-market and emerging-growth Life Sciences organizations.

Commenting on their appointment, Zechman said: "Lockton's success has always been based on developing innovative solutions for our clients in nuanced industries. We're excited to lead this practice, which will act as an extension of our clients' teams as we help them address today's risks and deliver proactive advice for what comes next."

More on The PennZone
  • Zenylitics Announces Leadership Transition to Continue Accelerated Growth
  • Wellness Technology Distributor Helping People Set Up Wellness Center Businesses
  • Christian Apocalyptic Thriller Explores Biblical Prophecy, Global Technology, & the Rise of the Ant
  • Turnstone Creative Expands Leadership Team with Addition of Marketing Manager
  • The Hidden Price Of Lost Property In UK Schools

The Life Sciences Practice will leverage Lockton's combined resources and technical expertise to help clients evaluate key exposures in depth, deliver data-driven recommendations to improve risk posture and build resilience, as well as design tailored insurance solutions that fit organizations' risk tolerance and goals.

Salvucci added: "Among Life Sciences companies and underwriters, Lockton has a reputation for independence and creativity. Brad and I look forward to working together to lead the Life Science Practice and help our clients achieve their objectives."
Filed Under: Business

Show All News | Disclaimer | Report Violation

0 Comments
1000 characters max.

Latest on The PennZone
  • Lord of the Rings, Doctor Who' Q&As, Local Sessions Highlight FAN EXPO Philadelphia Programming
  • Kryptokasinot.io Raises Concerns Over Proposed Cryptocurrency Restrictions in Finland's Gambling Reform
  • New Home of the Month: Spacious Luxury Meets Modern Design in The Bristol at Heritage at Manalapan
  • The Calida Group Announces Sale of Ely at Fort Apache for $57.5 Million
  • Tina Hasselbusch, co-founder and CEO of Turnstone Creative, Receives Circle of Excellence from Lehigh Valley Business
  • Summer Festivals in Gunma Prefecture: Song, Dance, and Vibrant Color – Get There Via Tobu Railway!
  • Jetperch Introduces Joulescope JS320 Precision Energy Analyzer for Low-Power Embedded System Development
  • AI-Powered Trading Bots Are Transforming Forex, Gold, and Digital Markets as DefiHash Expands Intelligent Quantitative Infrastructure
  • Early Bird Registration Open for FLYING HY, the Top Hydrogen and Battery Electric Aviation Event
  • Eichelberger Performing Arts Center Welcomes New Executive Director
  • Century Fasteners Corp. Hires Tony Marano as Director of Human Resources
  • Accelerating Toward Commercialization as FDA Momentum, AI Neurotherapy & Manufacturing Expansion Drive Multi-Catalyst Growth Story; N A S D A Q: NRXP
  • New Wisconsin Report Shows Most Plane Crashes Happen Outside Major Hubs
  • Thou Shalt not Commit Adultery Lifetime Movie Discussion
  • Book Florida Keys Accommodations Early with KeysCaribbean and Save 15 Percent
  • Color Card Administrator Highlights Growing Enterprise Demand for Workflow Orchestration in Enterprise Business Card Governance
  • Tennessee Laws Lead with Psychotropic Drug Testing in Mass Shooting Cases and Comprehensive Reporting: CCHR Urges Nationwide Adoption
  • Curious About Mensa? DFW Event Offers a 1-Day Immersion
  • Morphy's will breeze into summer with a June 10-11 Fine & Decorative Arts auction featuring nearly 1,200 high-quality lots
  • L-Tron to Exhibit at American Association for Motor Vehicle Administrators Region 1 Conference

Popular on PennZone

  • Virginia Moving Company Nearly Doubles Customer Calls in Two Weeks After Switching to CARL — the Bold New Alternative to WordPress
  • People & Stories/Gente y Cuentos Welcomes Two New Trustees as Organization Enters 54th Year and Expands Community Reach
  • Assymetrix Launches the Deepest Independent Prediction Market Data API
  • Resident Inspect Joins Property Meld Nexus Network with API Integration
  • New Homesites Released at Heritage at Manalapan Featuring Scenic Golf Course Views
  • RAS AP Consulting Advances to RFP Stage in Heidelberg Materials' SAP Vendor & Customer Master Data Modernization Initiative
  • Expert E-Bike Safety Advocate Issues Urgent Warning Following Recent Southern California Fatalities
  • "I'm Sicka Church Too: Give Me Kingdom!" Ignites a Powerful Call for Healing and Truth
  • CCHR: 'Plant-Based' Psychedelics Push Masks Synthetic Drugs and Billion-Dollar Profits
  • Veikkaus Appoints New CFO as Finland's Gambling Monopoly Braces for Breakup

Similar on PennZone

  • UK Financial Ltd Audits Full Ethereum Architecture Verifies Corporate Wallets and 19-Token Ecosystem Ahead of CoinMarketCap Filing for Global Ranking
  • Creative Investment Research Analysis Finds Slower GDP Growth, Rising Inflation
  • TechHouse Earns Highly Selective Microsoft Support Badge
  • J&J Exterminating Celebrates 65th Anniversary and Unveils Strategic Vision at Annual Team Meeting
  • Zenylitics Announces Leadership Transition to Continue Accelerated Growth
  • Wellness Technology Distributor Helping People Set Up Wellness Center Businesses
  • Milton Collier, CEO & President of Freight Broker 911, Eliminates the #1 Barrier to Entry in Logistics: Announces 100% Free Freight Broker Training
  • FDA-Cleared AI Neuropsychiatry Platform, Million-Dose Ketamine Manufacturing and Presidential Psychedelic Initiative Drive Growing Momentum for NRXP
  • Accelerating Toward Commercialization as FDA Momentum, AI Neurotherapy & Manufacturing Expansion Drive Multi-Catalyst Growth Story; N A S D A Q: NRXP
  • KRE PRIME Launches Adaptive Convertible Jumpsuit
Copyright © The PennZone | Theme: OMag by LilyTurf Themes
  • Contribute
  • Privacy Policy
  • Terms of Service
  • Contact Us